Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, completed a sale of 13,871 shares of common stock on November 4, 2024. The transaction was executed at a price of $8.6842 per share, resulting in a total sale value of approximately $120,458.54. Following the sale, Watanabe directly holds 832,392 shares of the company. Additionally, Watanabe has indirect ownership of 231,140 shares through various trusts and an LLC. The sale took place in the open market and was part of a planned disposition of shares.

Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, completed a sale of 13,871 shares of common stock on November 4, 2024. The transaction was executed at a price of $8.6842 per share, resulting in a total sale value of approximately $120,458.54. Following the sale, Watanabe directly holds 832,392 shares of the company. Additionally, Watanabe has indirect ownership of 231,140 shares through various trusts and an LLC. The sale took place in the open market and was part of a planned disposition of shares.